Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Pursuant to ....
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company has informed exchanges that a Board meeting is scheduled for May 21, 2026 to consider and adopt the audited financial results for Q4 and the financial year ended March 31, 2026. The company had already notified on March 19, 2026 that the trading window for insiders remains closed from March 31, 2026 until 48 hours after the results are declared. The filing is dated May 7, 2026 and signed by the Company Secretary.
Routine quarterly/annual results announcement. The stock may see increased volatility around the meeting date and following the results declaration, especially once the insider trading window reopens.